Praxis Precision Medicines, Inc. (PRAX)
NASDAQ: PRAX · Real-Time Price · USD
314.41
+6.21 (2.01%)
At close: Jul 17, 2026, 4:00 PM EDT
319.68
+5.26 (1.67%)
After-hours: Jul 17, 2026, 7:16 PM EDT
PRAX Stock Forecast
Stock Price Forecast
According to 18 analysts polled by S&P Global, PRAX stock has a consensus rating of "Buy" and an average price target of $619.11. The average 1-year stock price forecast is 96.91% higher than the current stock price, while the lowest is $162 (-48.47%) and the highest is $1,201 (+281.99%).
Price Target: $619.11 (+96.91%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for PRAX stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 13 | 12 | 13 | 13 | 13 | 13 |
| Buy | 2 | 2 | 2 | 2 | 3 | 3 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 17 | 16 | 17 | 17 | 18 | 18 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $1,200 | Buy | Maintains | $1,200 | +281.67% | Jul 13, 2026 |
Kevin Strang Jefferies No rating | Jefferies | Buy Initiates $447 | Buy | Initiates | $447 | +42.17% | Jul 13, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $449 | Buy | Maintains | $449 | +42.81% | Jul 11, 2026 |
| Raymond James | Raymond James | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Jul 1, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Reiterates $731 → $719 | Buy | Reiterates | $731 → $719 | +128.68% | Jun 30, 2026 |
Financial Forecast
Revenue This Year
2.82M
Revenue Next Year
342.36M
from 2.82M
Increased by 12,037.06%
EPS This Year
-15.30
from -13.48
EPS Next Year
-9.66
from -15.30
EPS and Forward PE are based on non-GAAP adjusted numbers.